Integrative multi-omics and experimental validation identify SERINC2 as a ferroptosis-related biomarker in idiopathic pulmonary fibrosis

Abstract Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited therapeutic options. Ferroptosis, an iron-dependent cell death, has been implicated in various fibrotic diseases, but its role in IPF remains unclear. This study integrates spatial transcriptomics, single-cell RNA sequencing, and bulk RNA-seq to explore ferroptosis in IPF. A ferroptosis scoring model and machine learning algorithms identified SERINC2 as a key gene upregulated across all datasets, with high expression in basal cells. Further analysis revealed that SERINC2⁺ basal cells are involved in key signaling pathways, such as Wnt and NT, and exhibit active intercellular communication. Animal experiments confirmed that SERINC2 protein levels are elevated in the lung tissues of BLM-induced mice, supporting its role in disease progression. Our findings suggest that SERINC2 may serve as a potential diagnostic biomarker and therapeutic target, providing new insights into the pathogenesis and potential treatment of IPF.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Medicine
Published
2026-09-11
DOI
https://doi.org/10.1007/s10238-026-02320-2
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Integrative multi-omics and experimental validation identify SERINC2 as a ferroptosis-related biomarker in idiopathic pulmonary fibrosis

Simiao Chen, Xiang Zhou, Bo Peng, Meifeng Li et al.
Clinical and Experimental Medicine
Ferroptosis and cancer prognosis
article

Integrative multi-omics and experimental validation identify SERINC2 as a ferroptosis-related biomarker in idiopathic pulmonary fibrosis

Simiao Chen, Xiang Zhou, Bo Peng, Meifeng Li, Xiaoyan Chang, Yupeng Zhao, Ran Xu, Linyou Zhang, Chenghao Wang
article en

Abstract

Abstract Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited therapeutic options. Ferroptosis, an iron-dependent cell death, has been implicated in various fibrotic diseases, but its role in IPF remains unclear. This study integrates spatial transcriptomics, single-cell RNA sequencing, and bulk RNA-seq to explore ferroptosis in IPF. A ferroptosis scoring model and machine learning algorithms identified SERINC2 as a key gene upregulated across all datasets, with high expression in basal cells. Further analysis revealed that SERINC2⁺ basal cells are involved in key signaling pathways, such as Wnt and NT, and exhibit active intercellular communication. Animal experiments confirmed that SERINC2 protein levels are elevated in the lung tissues of BLM-induced mice, supporting its role in disease progression. Our findings suggest that SERINC2 may serve as a potential diagnostic biomarker and therapeutic target, providing new insights into the pathogenesis and potential treatment of IPF.

Clinical and Experimental Medicine
Harbin Medical University (CN), Second Affiliated Hospital of Harbin Medical University (CN)
Good health and well-being
Openalex Percentile: Top 11%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Integrative multi-omics and experimental validation identify SERINC2 as a ferroptosis-related biomarker in idiopathic pulmonary fibrosis — Simiao Chen, Xiang Zhou, et al. · Clinical and Experimental Medicine (2026) | TGRS Research Map | TGRS